adapalene vs ruxolitinib topical
Side-by-side comparison of adapalene and ruxolitinib topical Data from FDA drug databases (Orange Book, NDC Directory, recalls, shortages) covering 20,000+ approved drugs, plus CMS pricing; see our methodology.
Differin
Opzelura
Adapalene and benzoyl peroxide gel is a medicine used on the skin to treat acne. It contains two medicines: adapalene (a retinoid) and benzoyl peroxide.
Opzelura is a cream that contains ruxolitinib. It is used on the skin to treat certain skin conditions.
This medicine treats acne, a skin condition with pimples and bumps. You can use this medicine if you are 9 years or older. Apply the gel to the affected areas of your face and/or trunk.
Opzelura treats mild to moderate atopic dermatitis (eczema) in adults and children 2 years and older. It is for when other prescription creams don't work well or are not recommended. Opzelura also treats nonsegmental vitiligo in adults and children 12 years and older.
Adapalene is a retinoid that helps to unclog pores and reduce inflammation. Benzoyl peroxide is an antibacterial medicine that kills acne-causing bacteria. Together, they help to clear up acne.
Opzelura contains a medicine called a Janus kinase (JAK) inhibitor. It works by blocking certain proteins in your body. These proteins are part of the process that causes skin inflammation and color loss.
- • Dry skin
- • Contact dermatitis (skin rash)
- • Burning feeling on the skin where you put the medicine
- • Skin irritation
- • Common cold
- • Diarrhea
- • Bronchitis
- • Ear infection
- • Increased eosinophil count
- The medicine did not work 51,276
- Dry skin 44,990
- Burning feeling on the skin 41,633
- Acne 39,264
- Redness 38,379
No adverse event reports.
When using this medicine, avoid sunlight and sunlamps. If you can't avoid the sun, wear sunscreen. This medicine may cause skin irritation, redness, scaling, dryness, stinging, or burning. If this happens, use a moisturizer or apply the medicine less often. If irritation is severe, stop using the medicine.
Opzelura may increase your risk of serious infections, cancer, blood clots, and major heart problems. Contact your doctor immediately if you develop any signs or symptoms of an infection, such as fever, cough, or sore throat. Tell your doctor if you have ever had tuberculosis, as it could become active again. If you have a heart attack or stroke, stop using Opzelura.
If you are pregnant, only use this medicine if the benefit outweighs the risk to the baby. It is not known if this medicine passes into breast milk, so talk to your doctor before using it if you are breastfeeding.
Tell your doctor if you are pregnant or plan to become pregnant. Opzelura may harm your unborn baby. You should not breastfeed while using Opzelura.
Also Compare — Nearby Drugs
Compare adapalene with
How to Read This adapalene vs ruxolitinib topical Comparison
adapalene is classified in the Retinoid (Topical) drug class, while ruxolitinib topical sits within the JAK Inhibitor (Topical) class. Drugs from different classes work through distinct mechanisms, so a head-to-head comparison illustrates trade-offs rather than equivalence. Both drugs are split between OTC and prescription status, which affects access and supervision.
Adverse event totals above are pulled from the FDA's Adverse Event Reporting System (FAERS). For these top-ranked reactions alone, adapalene has 215,542 submissions while ruxolitinib topical has 0. Those figures reflect cumulative reporting volume — not per-patient risk — so older, widely dispensed drugs typically look worse on count alone. No direct interaction between these two drugs is listed in our FDA-derived dataset, though co-prescription still warrants pharmacist review. Serious warnings, pregnancy guidance, and contraindications can differ even when indications overlap.
A table cannot substitute for clinical judgment. Effectiveness, tolerability, drug-drug interactions with your other medications, kidney and liver function, pregnancy status, insurance formulary, and price all feed into a decision that only a licensed prescriber can make responsibly. Data here is sourced from FDA Structured Product Labels (SPL) and FAERS, both of which update as manufacturers and clinicians submit new information. This page is for educational purposes only, is not medical advice, and should not be used to self-switch between adapalene and ruxolitinib topical — always consult your physician or pharmacist first.
Important: This comparison is for informational purposes only. Drug effects vary between individuals. Always consult your doctor or pharmacist for personalized medical advice.